Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention

Biochemical and Biophysical Research Communications

Volumn 453, Issue 1, 2014, Pages 106-111

  Meng, Fandong ^a   Li, Yan ^a   Tian, Xin ^a   Fu, Liye ^a   Yin, Yuanqin ^a   Sui, Chengguang ^a   Ma, Ping ^a   Jiang, Youhong ^a  

^a First Hospital of China Medical University   (China)

Author keywords

Abbreviations 5Z 5Z 7 oxozeanol; MTT 3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyl tetrazolium bromide; NF B nuclear factor B; RCC renal cell carcinoma shRNA small hairpin; RNA; TAK1; TGF activated kinase 1; VLB vinblastine sulfate

Indexed keywords

5Z 7 OXOZEANOL; ANTINEOPLASTIC AGENT; CASPASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYTAK 1; NG 25; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; VINBLASTINE SULFATE; 7-OXOZEANOL; LACTONE; MAP KINASE KINASE KINASE 7; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN KINASE INHIBITOR; RESORCINOL DERIVATIVE; RNA; SMALL INTERFERING RNA; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; ONCOGENE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL CELL CARCINOMA CELL LINE; ANTAGONISTS AND INHIBITORS; CARCINOMA, RENAL CELL; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; GENETICS; KIDNEY NEOPLASMS; METABOLISM; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; LACTONES; MAP KINASE KINASE KINASES; NF-KAPPA B; ONCOGENES; PROTEIN KINASE INHIBITORS; RESORCINOLS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TUMOR STEM CELL ASSAY; UP-REGULATION; VINBLASTINE;

EID: 84908373317     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.070     Document Type: Article

References (26)

1. R.J. Motzer, T.E. Hutson, D. Cella, J. Reeves, R. Hawkins, J. Guo, P. Nathan, M. Staehler, P. de Souza, J.R. Merchan, E. Boleti, K. Fife, J. Jin, R. Jones, H. Uemura, U. De Giorgi, U. Harmenberg, J. Wang, C.N. Sternberg, K. Deen, L. McCann, M.D. Hackshaw, R. Crescenzo, L.N. Pandite, and T.K. Choueiri Pazopanib versus sunitinib in metastatic renal-cell carcinoma N. Engl. J. Med. 369 2013 722 731
2. H.T. Cohen, and F.J. McGovern Renal-cell carcinoma N. Engl. J. Med. 353 2005 2477 2490
3. R.J. Motzer, N.H. Bander, and D.M. Nanus Renal-cell carcinoma N. Engl. J. Med. 335 1996 865 875
4. R.J. Amato Chemotherapy for renal cell carcinoma Semin. Oncol. 27 2000 177 186
5. B. Ljungberg, N.C. Cowan, D.C. Hanbury, M. Hora, M.A. Kuczyk, A.S. Merseburger, J.J. Patard, P.F. Mulders, and I.C. Sinescu EAU guidelines on renal cell carcinoma: the 2010 update Eur. Urol. 58 2010 398 406
6. J.P. Dutcher, and D. Nanus Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy Med. Oncol. 28 2011 1530 1533
7. Y.S. Roh, J. Song, and E. Seki TAK1 regulates hepatic cell survival and carcinogenesis J. Gastroenterol. 49 2014 185 194
8. H. Sakurai Targeting of TAK1 in inflammatory disorders and cancer Trends Pharmacol. Sci. 33 2012 522 530
9. S.E. Martin, Z.H. Wu, K. Gehlhaus, T.L. Jones, Y.W. Zhang, R. Guha, S. Miyamoto, Y. Pommier, and N.J. Caplen RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors Curr. Cancer Drug Targets 11 2011 976 986
10. D. Melisi, Q. Xia, G. Paradiso, J. Ling, T. Moccia, C. Carbone, A. Budillon, J.L. Abbruzzese, and P.J. Chiao Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 J. Natl. Cancer Inst. 103 2011 1190 1204
11. A. Singh, M.F. Sweeney, M. Yu, A. Burger, P. Greninger, C. Benes, D.A. Haber, and J. Settleman TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers Cell 148 2012 639 650
12. D.M. Ray, P.H. Myers, J.T. Painter, M.J. Hoenerhoff, K. Olden, and J.D. Roberts Inhibition of transforming growth factor-beta-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis Br. J. Cancer 107 2012 129 136
13. M.J. Ryan, G. Johnson, J. Kirk, S.M. Fuerstenberg, R.A. Zager, and B. Torok-Storb HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney Kidney Int. 45 1994 48 57
14. F.G. Yang, Z.W. Zhang, D.Q. Xin, C.J. Shi, J.P. Wu, Y.L. Guo, and Y.F. Guan Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines Acta Pharmacol. Sin. 26 2005 753 761
15. Y. Tu, C. Ji, B. Yang, Z. Yang, H. Gu, C.C. Lu, R. Wang, Z.L. Su, B. Chen, W.L. Sun, J.P. Xia, Z.G. Bi, and L. He DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival Mol. Cancer 12 2013 172
16. M. Yu, D.T. Ting, S.L. Stott, B.S. Wittner, F. Ozsolak, S. Paul, J.C. Ciciliano, M.E. Smas, D. Winokur, A.J. Gilman, M.J. Ulman, K. Xega, G. Contino, B. Alagesan, B.W. Brannigan, P.M. Milos, D.P. Ryan, L.V. Sequist, N. Bardeesy, S. Ramaswamy, M. Toner, S. Maheswaran, and D.A. Haber RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis Nature 487 2012 510 513
17. A. Zecevic, H. Menard, V. Gurel, E. Hagan, R. DeCaro, and A. Zhitkovich WRN helicase promotes repair of DNA double-strand breaks caused by aberrant mismatch repair of chromium-DNA adducts Cell Cycle 8 2009 2769 2778
18. A.R. Klatt, G. Klinger, O. Neumuller, B. Eidenmuller, I. Wagner, T. Achenbach, T. Aigner, and E. Bartnik TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha Biomed. Pharmacother. 60 2006 55 61
19. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
20. J. Zhang, K. Clark, T. Lawrence, M.W. Peggie, and P. Cohen An unexpected twist to the activation of IKKbeta: TAK1 primes IKKbeta for activation by autophosphorylation Biochem. J. 461 2014 531 537
21. E. Pauls, N. Shpiro, M. Peggie, E.R. Young, R.J. Sorcek, L. Tan, H.G. Choi, and P. Cohen Essential role for IKKbeta in production of type 1 interferons by plasmacytoid dendritic cells J. Biol. Chem. 287 2012 19216 19228
22. D. Oka, K. Nishimura, M. Shiba, Y. Nakai, Y. Arai, M. Nakayama, H. Takayama, H. Inoue, A. Okuyama, and N. Nonomura Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB Int. J. Cancer 120 2007 2576 2581
23. K.V. Gurova, J.E. Hill, C. Guo, A. Prokvolit, L.G. Burdelya, E. Samoylova, A.V. Khodyakova, R. Ganapathi, M. Ganapathi, N.D. Tararova, D. Bosykh, D. Lvovskiy, T.R. Webb, G.R. Stark, and A.V. Gudkov Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors Proc. Natl. Acad. Sci. U.S.A. 102 2005 17448 17453
24. M. Oya, A. Takayanagi, A. Horiguchi, R. Mizuno, M. Ohtsubo, K. Marumo, N. Shimizu, and M. Murai Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma Carcinogenesis 24 2003 377 384
25. T. Yu, J. Li, and H. Sun C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro Cancer Chemother. Pharmacol. 66 2010 999 1003
26. S. Buti, M. Bersanelli, A. Sikokis, F. Maines, F. Facchinetti, E. Bria, A. Ardizzoni, G. Tortora, and F. Massari Chemotherapy in metastatic renal cell carcinoma today? A systematic review Anticancer Drugs 24 2013 535 554